Eurofins Financial Statements From 2010 to 2025
| ERFSF Stock | USD 53.92 0.48 0.88% |
Check Eurofins Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eurofins Scientific's main balance sheet or income statement drivers, such as , as well as many indicators such as . Eurofins financial statements analysis is a perfect complement when working with Eurofins Scientific Valuation or Volatility modules.
Eurofins |
Eurofins Scientific SE Company Operating Margin Analysis
Eurofins Scientific's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Eurofins Scientific Operating Margin | 0.17 % |
Most of Eurofins Scientific's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eurofins Scientific SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Eurofins Scientific SE has an Operating Margin of 0.1656%. This is 100.47% lower than that of the Healthcare sector and 100.26% lower than that of the Diagnostics & Research industry. The operating margin for all United States stocks is 103.01% lower than that of the firm.
Eurofins Scientific Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Eurofins Scientific's current stock value. Our valuation model uses many indicators to compare Eurofins Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eurofins Scientific competition to find correlations between indicators driving Eurofins Scientific's intrinsic value. More Info.Eurofins Scientific SE is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.49 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Eurofins Scientific SE is roughly 2.03 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eurofins Scientific's earnings, one of the primary drivers of an investment's value.About Eurofins Scientific Financial Statements
Eurofins Scientific stakeholders use historical fundamental indicators, such as Eurofins Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Although Eurofins Scientific investors may analyze each financial statement separately, they are all interrelated. For example, changes in Eurofins Scientific's assets and liabilities are reflected in the revenues and expenses on Eurofins Scientific's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Eurofins Scientific SE. Please read more on our technical analysis and fundamental analysis pages.
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. Eurofins Scientific operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 61000 people.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Eurofins Pink Sheet
Eurofins Scientific financial ratios help investors to determine whether Eurofins Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eurofins with respect to the benefits of owning Eurofins Scientific security.